The State’s War on Competition (Part 1)
Medium US,
Classic Cases of Unjust Market Concentration A classic example brought up in support of the notion that markets tend towards…
Senate Health Committee Issues Testimony From Harvard Medical School Professor
Insurance News Net,
WASHINGTON, April 21 -- The Senate Health, Education, Labor and Pensions Committee issued the following written testimony by…
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
IT News Online,
Copyright 2023 PR Newswire. All Rights Reserved 2023-03-29 Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to…
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
SNN,
Sponsored: Advertising Content SOURCE SaveRxCanada.to Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to…
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
Spoke,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
VB Profiles,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
Ticker Tech,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
Benzinga,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
Le Lézard,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
Yahoo! Finance USA,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
Where to Buy Prescription Drugs from a Top Canadian Pharmacy
PR Newswire,
Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S.
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
NASDAQ,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Newsbreak,
What the research says YouGov and The Economist polled 1,500 U.S. adults earlier this month about prescription drug prices.
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Belleville News-Democrat ,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Olympian,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Telegraph (Georgia),
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Myrtle Beach,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Island Packet,
Eddie Lee / Money; More than a third of Americans — and disproportionately more women — have skipped filling a drug…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Ledger-Enquirer,
Eddie Lee / Money; More than a third of Americans — and disproportionately more women — have skipped filling a drug…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
News Tribune,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Bellingham Herald,
Eddie Lee / Money; More than a third of Americans — and disproportionately more women — have skipped filling a drug…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Charlotte Observer,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Bradenton Herald,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Herald,
| More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Merced Sun-Star,
Eddie Lee / Money; More than a third of Americans — and disproportionately more women — have skipped filling a drug…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Tri-City Herald,
Eddie Lee / Money; More than a third of Americans — and disproportionately more women — have skipped filling a drug…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Centre Daily Times,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Lexington Herald Leader,
By Adam Hardy Money Official Site – Finance News
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Star-Telegram,
Eddie Lee / Money; More than a third of Americans — and disproportionately more women — have skipped filling a drug…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Sun Herald,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Tribune,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
The Wichita Eagle,
More than a third of Americans — and disproportionately more women — have skipped filling a drug prescription because it costs…
More Than a Third of Americans Have Skipped Filling a Prescription Because of the Cost
Miami Herald,
By Adam Hardy MONEY RESEARCH COLLECTIVE March 12, 2023 Americans spend about $1,300 per year on prescription drugs — more than…
10 Everyday Activities That Count as a Workout
CNET,
Less than a quarter of US adults meet weekly exercise guidelines, according to the Centers for Disease Control and Prevention…
Mark Cuban’s Cost Plus Drugs Offers Prescription Medications at Huge Discounts
Health Reporter,
Mark Cuban’s Cost Plus Drugs propose des médicaments sur ordonnance à d’énormes rabais
News 24,
Que ce passe-t-il Mark Cuban a lancé une entreprise qui propose des versions génériques de médicaments à des prix extrêmement…
Mark Cuban's Cost Plus Drugs Offers Prescription Medications at Huge Discounts
CNET,
What's happening Mark Cuban started a company that offers generic versions of medications at extremely low prices.
Mark Cuban's Cost Plus Drugs Offers Prescription Medications at a Huge Discount - Health Reporter
Health Reporter,
What’s happening Mark Cuban started a company that offers generic versions of medications at extremely low prices.
Mark Cuban's Cost Plus Drugs Offers Prescription Medications at a Huge Discount
CNET,
What's happening Mark Cuban started a company that offers generic versions of medications at extremely low prices.
Mark Cuban's Cost Plus Drugs Sells Prescription Medications at a Huge Discount
MSN,
Billionaire entrepreneur Mark Cuban's new company, which publicly launched in January, is selling hundreds of generic, commonly…
Mark Cuban's Cost Plus Drugs Sells Prescription Medications at a Huge Discount
CNET,
What's happening Mark Cuban started a company that offers generic versions of medications at extremely low prices.
Médicaments à prix coûtant plus : la start-up de pharmacie de Mark Cuban vend des médicaments ultra-bon marché
News 24,
Que ce passe-t-il Mark Cuban a lancé une entreprise qui propose des versions génériques de médicaments à des prix extrêmement…
Medicare could have saved $3 billion buying drugs the Mark Cuban way
The Keene Sentinel ,
Many of our patients struggle to afford their medicines, and it’s agonizing to have a front-row seat to this injustice.
Medicare could have saved $3 billion buying drugs the Mark Cuban way
Washington Post,
Hussain S. Lalani is a physician at Brigham and Women’s Hospital and a fellow at the Program on Regulation, Therapeutics and…
Cost Plus Drugs: Mark Cuban's New Company Sells Ultra-Cheap Prescriptions
CNET,
What's happening Mark Cuban started a company that offers generic versions of medication at extremely low prices.
Why Won’t Congress Do What Mark Cuban Is Doing For Affordable Drug Prices?
Forbes,
pm EDT|New! Click on the conversation bubble to join the conversation Got it! You’ve probably heard of Mark Cuban, billionaire…
How Mark Cuban’s New Drug Company Sells Medications With Huge Discounts
awsforwp,
What’s happening Mark Cuban started a company that offers generic versions of medication at extremely low prices.
How Mark Cuban's New Drug Company Sells Medications With Huge Discounts
CNET,
What's happening Mark Cuban started a company that offers generic versions of medication at extremely low prices.
Prices for New Drugs Are Rising 20 Percent a Year. Congress Needs to Act.
DNYUZ,
Millions of Americans are forced to ration or go without prescription drugs because of their high cost.
Big Pharma Handling Vaccine Rollout Was A Mistake
The ASEAN Post,
Pfizer has had an exceptionally good pandemic. The company announced that its COVID-19 vaccine brought in US$37 billion last…
Will parents trust Pfizer’s pediatric vaccine after a new postponement?
Poynter,
Plus, new data says a fourth dose might be necessary, vaccines are working well for teens, remdesivir appears to work against…
Letting big pharma lead the global vaccine rollout was a mistake - Taipei Times
Taipei Times,
The COVID-19 pandemic made one fact perfectly clear: Pharmaceutical companies and their shareholders only care about huge…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Google News,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake
MSN,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Newsbreak,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Tech Register,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Newscabal,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake
Yahoo! News,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
The Guardian,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Comment: Negotiating drug prices won’t hurt innovation
HeraldNet,
By Aaron S. Kesselheim and Jerry Avorn / Special To The Washington Post For years, the pharmaceutical industry has managed to…
Letting the government negotiate drug prices won’t hurt innovation
Washington Post,
For years, the pharmaceutical industry has managed to fend off legislative efforts to tame America’s brand-name medication…
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
MSN,
There is increasing interest in the federal government in lowering prescription drug prices.
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
Newsbreak,
There is increasing interest in the federal government in lowering prescription drug prices.
One key study highlights how cancer-drug prices continue to rise in the US — even if they don't elsewhere
Business Insider,
There is increasing interest in the federal government in lowering prescription drug prices.
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
Business Insider India,
As the federal government considers a plan to lower the price of some costly drugs, researchers have found that while US cancer-d…
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
Business Insider Australia ,
There is increasing interest in the federal government in lowering prescription drug prices.
Government regulated or negotiated drug prices: Key design considerations
Brookings,
By Paul Ginsburg, Steven M. Lieberman Government regulated or negotiated drug prices: Key design considerations Paul B.
News story from Gizmodo Australia on Tuesday 04 May 2021
Gizmodo Australia,
News story from Gizmodo on Tuesday 04 May 2021
Gizmodo,
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
Single-Payer Drug Pricing In A Multipayer Health System: Does Germany Offer A Model For The US?
Health Affairs,
An increasing number of presidential hopefuls, most recently Senator Kamala Harris, are proposing “single payer” or “Medicare…
Drug Prices by Committee: One Way Biden Could Lower Costs
New York Times,
The New Health Care Many countries use independent review boards to balance innovation and profit.
Blame medication price gouging on spineless politicians
Newsbreak,
Thought Catalog/Unsplash An article published in Journal of the American Medical Association spells out just why prescription…
Balancing Lower U.S. Prescription Drug Prices And Innovation – Part 2
Health Affairs,
In Part 1 of this post, we provided background on U.S. drug prices and summarized an expert roundtable discussion held in June…
Balancing Lower U.S. Prescription Drug Prices And Innovation – Part 1
Health Affairs,
Most Americans believe U.S. prescription drug prices are too high—a conclusion reinforced by almost 3 in 10 Americans reporting…
Balancing lower U.S. prescription drug prices and innovation – Part 1
Brookings,
By Steven M. Lieberman, Paul Ginsburg, Kavita Patel Most Americans believe U.S.
Stop Paying Too Much For Your IPOs - Get GoodRx Today
Seeking Alpha,
Summary GoodRx has managed to marry technology with a lasting, polarizing and colossal issue impacting society - healthcare…
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
News story from Eurasia Review on Wednesday 25 March 2020
Eurasia Review,
The Decade of Transformation Is Here: Remaking Health Care
Globalresearch,
We’ve been writing for a while that the 2020’s would be a decade when multiple crises would come to a head and we would have an…
Fact check: Is Big Pharma’s take on the Pelosi drug-pricing bill fair warning or fearmongering?
Bozeman Daily Chronicle,
House Speaker Nancy Pelosi’s flagship proposal to curb prescription drug prices, the “Lower Drug Costs Now Act” — H.R.
Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?
The Medical News,
House Speaker Nancy Pelosi's flagship proposal to curb prescription drug prices, the "Lower Drug Costs Now Act" - H.R.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
Lancaster Online,
House Speaker Nancy Pelosi’s flagship proposal to curb prescription drug prices, the “Lower Drug Costs Now Act” ― H.R.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The Record,
[khn—slabs slabs="1027675" view="inline" /] [partner-box]House Speaker Nancy Pelosi’s flagship proposal to curb prescription…
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
Kaiser Health News,
“Speaker Pelosi’s drug pricing plan would siphon $1 trillion or more from biopharmaceutical innovators over the next 10 years.
House Commerce Committee Issues Hearing Memo on Making Prescription Drugs More Affordable
Insurance News Net,
Targeted News Service WASHINGTON, Sept. 18 -- The House Energy and Commerce Committee issued the following hearing memorandum…
Why a plan to lower prescription drug prices should not be piecemeal
MedicalXpress,
A man looks at a prescription drug bottle. Many Americans will chronic conditions report rationing their drugs because of cost.
Why a plan to lower prescription drug prices should not be piecemeal
Toronto Telegraph,
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic…
News story from Big News Network on Tuesday 10 September 2019
Big News Network,
MIL-OSI Global: Why a plan to lower prescription drug prices should not be piecemeal
Foreign Affairs New Zealand,
Post sponsored by NewzEngine.com Source: The Conversation – USA – By Minal R. Patel, Associate Professor of Health Behavior
Why a plan to lower prescription drug prices should not be piecemeal
Idaho Press,
( is an independent and nonprofit source of news, analysis and commentary from academic experts.), and, (THE CONVERSATION…
Why a plan to lower prescription drug prices should not be piecemeal
Lincoln Journal Star,
(THE CONVERSATION) Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at…
Why a plan to lower prescription drug prices should not be piecemeal
SFGate,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Minal R.
Why a plan to lower prescription drug prices should not be piecemeal
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Minal R.
Why a plan to lower prescription drug prices should not be piecemeal
The Conversation,
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic…
Price of snakebite drug is sky high, likely to stay that way
Union Leader,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Price of snakebite drug is sky high, but new competitor unlikely to lower costs
The Medical News,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WCBE ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KOSU,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KTEP El Paso,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …